This second edition of The Trademarks Law Review seeks to build on the foundations laid in the first edition. The overall objectives remain the same: first, to provide an annual snapshot of trademark law across a broad range of jurisdictions, summarising key legal provisions and also examining recent developments and trends from the courts, and second, to identify areas of expected legal activity and legislative change going forward.
2018 has been a watershed year for the privacy field. The European Union’s General Data Protection Regulation (GDPR) has been the main attraction. Companies subject to the GDPR have expended and will continue to expend enormous efforts and funds to understand and diagram their data-processing operations. Now that the GDPR has gone live, as of 25 May 2018, it remains to be seen how the Member State data protection authorities will deploy their significant new penalty authority to enforce substantially more stringent standards. Will US tech companies continue to bear the brunt of EU enforcement wrath, or will the DPAs scrutinise inwards as well?
Welcome to the second edition of The Healthcare Law Review. The Review provides an introduction to healthcare economies and their legal frameworks in 17 jurisdictions, with new contributions from Japan, Korea and Finland. These new chapters, together with updates to the jurisdictions previously covered in the first edition, only serve to emphasise that this is a constantly changing environment. While hugely diverse, it is possible to discern common challenges and similar approaches in very different countries.
Intellectual property is taking a more and more central position in the global economy, and this is true not only in highly developed economies, but also in emerging ones. China and India, to take just two examples, are moving rapidly up the value chain and now have world-class technology companies for which intellectual property protection is crucial.
This first edition of The Financial Technology Law Review is published at a time when most players in the finance sector are concerned about the new developments that information technology (IT), big data and artificial intelligence (AI). Hence, it is often forgotten that the use of IT in the finance sector is not new and that many applications that would come under fintech are already quite old, at least by today’s standards.
The Life Sciences Law Review covers a total of 35 jurisdictions, providing an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies. The chapters are arranged to describe requirements throughout the life cycle of a regulated product, from discovery to clinical trials, the marketing authorisation process and post-approval controls. Certain other legal matters of special interest to manufacturers of medical products.
Consumer choice for financial products and services is proliferating across global markets. The ability to reach consumers at any time on their mobile phones, tablets or other devices has helped attract substantial capital investment in consumer financial services.
Franchising, in its various forms, continues to present businesses with one way of achieving profitable and successful international growth without the need for either substantial capital investment or a broad managerial infrastructure. In sectors as diverse as food and beverage, retail, hospitality, education, healthcare and financial services.